Anterior Ethmoidal Nerve Block in Prevention of Postoperative Agitation

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03427502
• Date of registration: 02/02/2018
• Prospective Registration: Yes
• Primary sponsor: Lumbini Medical College
• Public title: Anterior Ethmoidal Nerve Block in Prevention of Postoperative Agitation
• Scientific title: Anterior Ethmoidal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries With Nasal Packs Under General Anesthesia: A Double Blind Randomized Control Trial
• Date of first enrolment: June 1, 2018
• Target sample size: 100
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03427502
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).
• Phase: N/A

Countries of recruitment

Nepal

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients undergoing nasal surgery

- Under General Anesthesia

- With nasal packs

Exclusion Criteria:

- Do not consent to the study.

- History of allergy to lignocaine or bupivacaine



Age minimum: N/A
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Deviated Nasal Septum

Chronic Rhinosinusitis (Diagnosis)

Nasal Polyps

Postoperative Agitation: Impaired Awareness, Abnormal Cognitive Function, Confusion, and Verbal and Physical Agitation During Recovery From General Anesthesia

Intervention(s)

Drug: Bupivacaine-epinephrine

Drug: normal saline

Primary Outcome(s)

Postoperative agitation [Time Frame: 30 minutes after first score.]

Postoperative agitation [Time Frame: After extubation before leaving operation table, an average of 10 minutes]

Postoperative agitation [Time Frame: 9:00 AM next morning]

Secondary ID(s)

139

Source(s) of Monetary Support

Please refer to primary and secondary sponsors